Research design has a significant impact on our daily lives as well as our understanding of how things work, our universe and the world and societies we live in. Most research funders want to ensure that the research teams they are funding are reflective of our society but increasingly many now want to ensure that diversity, particularly, gender and sex diversity are considered in research design.
Drawing on practical examples of approaches to and impact of research, evidence and informed practice the event will appeal to academics and professional staff involved in the development of research strategy and research grant applications as well as those leading and implementing research projects.
- The consideration of sex and gender in research design and how it intersects with other equality areas.
- Considering how we can build EDI into research design in our own research areas.
- The impact of consideration of gender and sex in research design and how its consideration, in comparison to previous approaches, has resulted in different outcomes for gender and sex equity.
Who should attend?
This event will appeal to academics and professional staff involved in the development of research strategy and research grant applications as well as those leading and implementing research projects. Equality and diversity practitioners, HE lecturers, staff involved with Athena SWAN charter applications and anyone else with responsibility for advancing equality and diversity within their institution would also benefit from participation in the event.
Professor Londa Schiebinger - Gendered Innovations - Why do we need to consider gender in research design?
Londa Schiebinger is the John L. Hinds Professor of History of Science in the History Department at Stanford University and Director of the EU/US Gendered Innovations in Science, Health & Medicine, Engineering, and Environment Project. From 2004-2010, Schiebinger served as the Director of Stanford's Clayman Institute for Gender Research. She is a member of the American Academy of Arts and Sciences.
Elizabeth Pollitzer PhD - The multi-level influences and benefits of integrating gender dimensions into research and innovation
Elizabeth Pollitzer trained originally in Biophysics and obtained PhD in Information Science from the University of London (Kings’ College). She spent more than 20 years as researcher and lecturer at the Department of Computing at Imperial College, London. Elizabeth is director of Portia, a not-for-profit organisation she co-founded in 2001 with several women scientists and engineers at Imperial College. Portia's aim is to use scientific evidence to advance understanding and actions towards greater awareness of how gender issues impact on science values, knowledge, and quality of outcomes.
Ellen Pugh is a Senior Adviser for Advance HE, specialising in Equality, Diversity and Inclusion. Ellen has worked to promote EDI in the HE and FE sector since 2004 and joined former ECU in 2009. She previously worked as Policy Director at Skill: National Bureau for Students with Disabilities (now Disability Rights UK) and in the governance division at the London School of Economics and Political Science. She has worked with research intensive, small and specialist and post 1992 institutions and with a range of sector and government organisations on EDI issues covering staff, students, applicants and alumni.
Lilian received their PhD in Genetics from UCL whilst at The Francis Crick Institute. It was here that they helped bring together Wellcome, The Francis Crick Institute and GSK as founders of EDIS (Equality, Diversity and Inclusion in Science and Health) in 2016, and have developed the coalition since. Lilian has previously represented EDIS on the National Institute for Health Research’s INVOLVE Diversity and Inclusion working group, with a focus on inclusive patient and public involvement in health research. They champion inclusive research design and practice within Wellcome and EDIS member organisations and sit as an Advisory Board Member for The Health Foundation’s ‘Developing the long-term research agenda for COVID-19’ programme.